Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Schrodinger, Inc. - Common Stock
(NQ:
SDGR
)
21.12
+0.16 (+0.76%)
Streaming Delayed Price
Updated: 1:00 PM EDT, Jul 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Schrodinger, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
July 01, 2025
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
June 30, 2025
Via
ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
June 28, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia
June 27, 2025
From
Schrödinger
Via
Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
June 26, 2025
Via
ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
June 25, 2025
Via
ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
June 24, 2025
Via
ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
June 23, 2025
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
June 20, 2025
Via
ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
June 18, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 17, 2025
From
Schrödinger
Via
Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
June 15, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Schrödinger Reports Encouraging Initial Phase 1 Clinical Data for SGR-1505 at EHA Annual Congress
June 12, 2025
From
Schrödinger
Via
Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
June 10, 2025
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
June 06, 2025
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
June 02, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer
May 29, 2025
From
Schrödinger
Via
Business Wire
Schrödinger Expands Executive Leadership Team with Appointment of Mannix Aklian as Chief Commercial Officer, Global Head of Software Sales and Marketing
May 29, 2025
From
Schrödinger
Via
Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
May 28, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 23, 2025
From
Schrödinger
Via
Business Wire
Schrödinger to Present at Jefferies Global Healthcare Conference
May 22, 2025
From
Schrödinger
Via
Business Wire
Schrödinger Announces CFO Appointment
May 20, 2025
From
Schrödinger
Via
Business Wire
Schrödinger to Present Phase 1 Clinical Data on MALT1 Inhibitor SGR-1505 at EHA Annual Congress and International Conference on Malignant Lymphoma
May 14, 2025
From
Schrödinger
Via
Business Wire
Schrödinger Reports Strong First Quarter 2025 Financial Results
May 07, 2025
From
Schrödinger
Via
Business Wire
Schrödinger to Present at BofA Securities 2025 Healthcare Conference
May 05, 2025
From
Schrödinger
Via
Business Wire
Schrödinger Presents New Preclinical Data at AACR Annual Meeting
April 28, 2025
From
Schrödinger
Via
Business Wire
Schrödinger to Announce First Quarter 2025 Financial Results on May 7
April 23, 2025
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
April 18, 2025
From
Schrödinger
Via
Business Wire
Schrödinger’s Statement Regarding FDA Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
April 14, 2025
From
Schrödinger
Via
Business Wire
Schrödinger to Present Preclinical Data at AACR Annual Meeting
March 25, 2025
From
Schrödinger
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.